Press Releases - 2023-01-11

Date	Title	Company
11-Jan-2023	HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)	HighTide Therapeutics Inc.
11-Jan-2023	Samsung Biologics receives the Terra Carta Seal in recognition of the company’s commitment to creating a sustainable future	Samsung Biologics
11-Jan-2023	ABL SA group acquires Berlin based Medtech company Humedics	ABL SA
11-Jan-2023	BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer	BioXcel Therapeutics
11-Jan-2023	Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)	Zenas BioPharma
11-Jan-2023	UK independent clinical trial sites running research on new medicines continue to prosper despite the decline at NHS sites	Panthera
11-Jan-2023	Valo Therapeutics selects Exothera to develop large-scale oncolytic adenovirus manufacturing	Valo Therapeutics
11-Jan-2023	Pain Management Drugs Market is anticipated to expand at a CAGR of 3.9% through 2032 \| insightSLICE	insightSLICE
11-Jan-2023	Rising prevalence of neurological disorders is driving the sales of Neuroprosthetics Market \| insightSLICE	insightSLICE
11-Jan-2023	Growing incidence of blood disorders is driving the sales of Hematology Diagnostics Market \| insightSLICE	insightSLICE
11-Jan-2023	Growing awareness regarding women’s health and wellness in developing countries is driving the sales of Femtech Market \| insightSLICE	insightSLICE
11-Jan-2023	Increasing prevalence of long-term diseases is driving the sales of Contrast Media Market \| insightSLICE	insightSLICE
11-Jan-2023	Aesthetic Lasers And Energy Devices Market to achieve CAGR of 9.3% through 2032 \| insightSLICE	insightSLICE
11-Jan-2023	Keranova’s FemtoMatrix technology produces unprecedented results in clinical regulatory trials	Andrew Lloyd Associates
11-Jan-2023	Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program	Avance Clinical
11-Jan-2023	Ethics Approval granted for significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial	Chanelle McCoy Health
11-Jan-2023	Evolva delivers strong results with 57% revenue growth and increasing margins	Evolva Holding SA